CBMG to manufacture CAR-T Kymriah for Chinese market under partnership with Novartis
The deal will bring the CAR-T therapy to China's burgeoning market, but it faces competition from Gilead's Yescarta - manufactured under a JV with Fosun - and also homegrown products.